Combined drugs and therapy most effective for severe nonchronic depression

August 20, 2014
Credit: George Hodan/Public Domain

The odds that a person who suffers from severe, nonchronic depression will recover are improved by as much as 30 percent if they are treated with a combination of cognitive therapy and antidepressant medicine rather than by antidepressants alone. However, a person with chronic or less severe depression does not receive the same additional benefit from combining the two.

That is the result of a major new clinical trial published online by the journal JAMA Psychiatry on Aug. 20.

In North America, about one in five women and one in 10 men suffer from in her or his lifetime.

"Our results indicate that combining with antidepressant medicine can make a much bigger difference than we had thought to about one-third of patients suffering from major depressive disorder," said Steven Hollon, the Gertrude Conaway Professor of Psychology at Vanderbilt University, who directed the study. "On the other hand, it does not appear to provide any additional benefit for the other two-thirds."

Previous studies have found that about two-thirds of all patients with major depressive disorder will improve on antidepressant medications and about one-third of patients will achieve full remission, but half then relapse before fully recovering. Cognitive therapy has proven to be about as effective as medication alone but its effects tend to be longer lasting. Combining the two has been estimated to improve recovery rates by 6 to 33 percent.

"Now, we have to reconsider our general rule of thumb that combining the two treatments keeps the benefits of both," said Hollon.

The new study was a involving 452 adult outpatients with chronic or recurrent major . Unlike previous studies that followed subjects for a set period of time, this study treated them for as long as it took first to remission (full normalization of symptoms) and then to recovery (six months without relapse), which in some cases took as long as three years.

"This provided us with enough data so that we could drill down and see how the combined treatment was working for patients with different types and severity of depression: chronic, recurrent, severe and moderate," Hollon said.

According to the psychologist, the results could have a major impact on how is treated. The most immediate effect is likely to be in the United Kingdom, which, he said, is 10 years ahead of the United States in treatment of depression. The use of combined cognitive therapy and antidepressive medicine is standard for severe cases in the UK, and the English National Health Service is actively training its therapists in cognitive therapy and other empirically supported psychotherapies.

Explore further: Does depression require hospitalization?

More information: JAMA Psychiatry. Published online August 20, 2014. doi:10.1001/jamapsychiatry.2014.1054
JAMA Psychiatry. Published online August 20, 2014. doi:10.1001/jamapsychiatry.2014.1524

Related Stories

Does depression require hospitalization?

July 7, 2014
A study published in the current issue of Psychotherapy and Psychosomatics has analyzed the difference between day hospital and inpatient stay in depression. Depending on the severity of depression, patients may be treated ...

Behavioral therapy in pediatric antidepressant treatment reduces likelihood of relapse

July 2, 2014
Cognitive behavioral therapy in addition to medication improves the long-term success of treatment for children and adolescents suffering from depression, a new UT Southwestern Medical Center study indicates.

Depression often untreated in Parkinson's disease

August 15, 2014
Depression is known to be a common symptom of Parkinson's disease, but remains untreated for many patients, according to a new study by Northwestern Medicine investigators in collaboration with the National Parkinson's Foundation ...

Continuation phase cognitive therapy beneficial in depression

September 5, 2013
(HealthDay)—For patients with major depressive disorder, continuation phase cognitive therapy (C-CT) and fluoxetine prevent relapse; and, a cognitive behavioral prevention (CBP) program provides lasting benefits for some ...

Recommended for you

Communicating in a foreign language takes emotion out of decision making

August 16, 2017
If you could save the lives of five people by pushing another bystander in front of a train to his death, would you do it? And should it make any difference if that choice is presented in a language you speak, but isn't your ...

US antidepressant use jumps 65 percent in 15 years

August 15, 2017
(HealthDay)—The number of Americans who say they've taken an antidepressant over the past month rose by 65 percent between 1999 and 2014, a new government survey finds.

Child's home learning environment predicts 5th grade academic skills

August 15, 2017
Children whose parents provide them with learning materials like books and toys and engage them in learning activities and meaningful conversations in infancy and toddlerhood are likely to develop early cognitive skills that ...

Precision medicine opens the door to scientific wellness preventive approaches to suicide

August 15, 2017
Researchers have developed a more precise way of diagnosing suicide risk, by developing blood tests that work in everybody, as well as more personalized blood tests for different subtypes of suicidality that they have newly ...

Obesity and depression are entwined, yet scientists don't know why

August 15, 2017
About 15 years ago, Dr. Sue McElroy, a psychiatrist in Mason, Ohio, started noticing a pattern. People came to see her because they were depressed, but they frequently had a more visible ailment as well: They were heavy.

Givers really are happier than takers

August 15, 2017
(HealthDay)—Generosity really is its own reward, with the brain seemingly hardwired for happiness in response to giving, new research suggests.

1 comment

Adjust slider to filter visible comments by rank

Display comments: newest first

James Fugedy
5 / 5 (1) Aug 21, 2014
Transcranial direct current stimulation (tDCS) provides relief for treatment-resistant depression, the 40% of patients who do not respond to antidepressants. tDCS is done with a portable stimulator powered by a 9 volt battery and sponge electrodes over targeted areas of the brain. tDCS is painless, non-invasive, easy to do and without side effects. tDCS can be self-administered with appropriate training and supervision. tDCS also provides relief for chronic pain, including migraine and fibromyalgia. In studies funded by the Department of Defense, tDCS enhanced learning and memory. tDCS is available in Atlanta, Boston and New York.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.